For a neonate whose mother has tuberous sclerosis complex and who has a fetal cardiac rhabdomyoma, what treatments and monitoring should be implemented in the NICU?

NICU Management for Neonate with TSC and Cardiac Rhabdomyoma

For a neonate with tuberous sclerosis complex (TSC) and fetal cardiac rhabdomyoma, immediate echocardiographic assessment is critical to evaluate for hemodynamic compromise, followed by comprehensive multisystem surveillance including brain MRI, renal imaging, and continuous cardiac monitoring for arrhythmias—most cardiac rhabdomyomas regress spontaneously, but symptomatic cases require mTOR inhibitor therapy (everolimus or sirolimus).

Immediate NICU Priorities

Cardiac Assessment and Monitoring

The cardiac rhabdomyoma requires urgent evaluation for three life-threatening complications 1:

• Perform echocardiography immediately to assess:

  • Tumor size, number, and location
  • Inflow/outflow tract obstruction (especially mitral or aortic)
  • Degree of ventricular dysfunction
  • Presence of arrhythmias

• Continuous cardiac monitoring for arrhythmias, which can be life-threatening even before tumor shrinkage occurs 2, 3

  • Supraventricular tachycardia and ventricular arrhythmias are most common
  • Arrhythmias may require aggressive antiarrhythmic therapy and inotropic support 3

• Serial echocardiograms: If initial echo is negative, repeat once. If positive and asymptomatic, repeat every 1-3 years until regression 1

Treatment Indications

Observation alone is appropriate for asymptomatic rhabdomyomas, as approximately two-thirds regress spontaneously during infancy 4, 5.

mTOR inhibitor therapy (everolimus or sirolimus) is indicated for 2, 6, 3:

• Hemodynamically significant obstruction (inflow/outflow tract)
• Malignant or refractory arrhythmias
• Heart failure symptoms
• Tumors causing significant mitral or tricuspid regurgitation

Evidence shows 90.9% clinical improvement and 95.1% tumor size reduction with mTOR inhibitors 6. Importantly, arrhythmias may improve rapidly even before tumor shrinkage 2.

Comprehensive TSC Surveillance in NICU

Neurological Assessment

Brain MRI (non-contrast) should be performed at diagnosis 1 to evaluate for:

• Cortical/subcortical tubers
• Subependymal nodules
• Subependymal giant cell astrocytomas (SEGAs)
• Other neuronal migration defects

Seizure monitoring and management:

• Educate parents about seizure recognition
• Immediate neurology referral if seizures occur
• TSC is a leading cause of infantile spasms

Renal Evaluation

Baseline renal imaging at diagnosis 7, 1:

• Renal ultrasound is acceptable in neonates (performed by expert radiologist)
• Assess for angiomyolipomas and cysts
• Baseline blood pressure measurement
• Renal function testing (though CKD is rare in neonates)

Follow-up renal imaging: Every 1-3 years if baseline negative 7, 1

Ophthalmologic Examination

Complete dilated fundoscopic exam at diagnosis 1:

• Screen for retinal astrocytomas (present in 30-50% of TSC patients)
• Annual follow-up recommended

Dermatologic Assessment

Skin examination at diagnosis 1 for:

• Hypomelanotic macules (ash-leaf spots)
• Facial angiofibromas (may not be present in neonates)
• Shagreen patches
• Ungual fibromas

Critical Pitfalls to Avoid

1. Do not assume asymptomatic rhabdomyomas are benign: Arrhythmias can develop suddenly and be life-threatening 8, 2, 3

2. Do not delay mTOR inhibitor therapy in symptomatic cases—clinical improvement often precedes tumor shrinkage 2

3. Do not use vasopressin analogues (desmopressin) if renal cysts are present, even for nocturnal enuresis 7

4. Do not assume normal initial imaging excludes future complications: TSC manifestations develop progressively with age 7

5. Monitor for hypothermia during prolonged resuscitation or evaluation 9

Genetic Confirmation and Counseling

• Genetic testing for TSC1/TSC2 mutations should be pursued
• Two-thirds to three-fourths of TSC cases are de novo mutations 4
• TSC2 variants generally present with more severe phenotypes, including earlier and more aggressive renal angiomyolipomas 1
• Maternal evaluation may be warranted if not already diagnosed

Discharge Planning

Before NICU discharge, ensure:

• Cardiology follow-up arranged (frequency based on tumor characteristics)
• Neurology referral completed
• Ophthalmology appointment scheduled
• Renal imaging and follow-up planned
• Family education on seizure recognition
• Multidisciplinary TSC clinic referral if available 1

The prognosis for cardiac rhabdomyomas is generally favorable with appropriate monitoring, as most regress spontaneously 10, 5. However, the overall TSC prognosis depends on neurological involvement, which is the primary determinant of long-term morbidity and quality of life.